DK287886D0 - N-(2-aminoacylamido-2-desoxyhexosyl)-amider, -carbamater og -urinstoffer, deres fremstilling og anvendelse som laegemidler samt mellemprodukter ved fremstillingen - Google Patents

N-(2-aminoacylamido-2-desoxyhexosyl)-amider, -carbamater og -urinstoffer, deres fremstilling og anvendelse som laegemidler samt mellemprodukter ved fremstillingen

Info

Publication number: DK287886D0
Authority: DK; Denmark
Prior art keywords: preparation; denotes hydrogen; carbon atoms; alkyl radical; intermediates
Prior art date: 1985-06-20

Application number

DK287886A

Other languages

English (en)

Other versions

DK287886A (da

Inventor

Oswald Lockhoff

Yutaka Hayauchi

Peter Stadler

Klaus Georg Stuenkel

Gert Streissle

Arnold Paessens

Volker Klimetzek

Hans-Joachim Zeiler

Karl Georg Metzger

Hein-Peter Kroll

Helmut Brunner

Klaus Schaller

Original Assignee

Bayer Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1985-06-20

Filing date

1986-06-19

Publication date

1986-06-19

1986-06-19 Application filed by Bayer Ag filed Critical Bayer Ag

1986-06-19 Publication of DK287886D0 publication Critical patent/DK287886D0/da

1986-12-21 Publication of DK287886A publication Critical patent/DK287886A/da

Links

239000000543 intermediate Substances 0.000 title abstract 2
229940126601 medicinal product Drugs 0.000 title 1
-1 mercaptomethyl Chemical group 0.000 abstract 9
229910052739 hydrogen Inorganic materials 0.000 abstract 6
239000001257 hydrogen Substances 0.000 abstract 6
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 3
125000004432 carbon atom Chemical group C* 0.000 abstract 3
150000002431 hydrogen Chemical class 0.000 abstract 2
229920006395 saturated elastomer Polymers 0.000 abstract 2
125000006701 (C1-C7) alkyl group Chemical group 0.000 abstract 1
125000004066 1-hydroxyethyl group Chemical group [H]OC([H])([*])C([H])([H])[H] 0.000 abstract 1
UTQNKKSJPHTPBS-UHFFFAOYSA-N 2,2,2-trichloroethanone Chemical group ClC(Cl)(Cl)[C]=O UTQNKKSJPHTPBS-UHFFFAOYSA-N 0.000 abstract 1
125000000143 2-carboxyethyl group Chemical group [H]OC(=O)C([H])([H])C([H])([H])* 0.000 abstract 1
125000004042 4-aminobutyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])N([H])[H] 0.000 abstract 1
125000003143 4-hydroxybenzyl group Chemical group [H]C([*])([H])C1=C([H])C([H])=C(O[H])C([H])=C1[H] 0.000 abstract 1
125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 abstract 1
239000003242 anti bacterial agent Substances 0.000 abstract 1
229940088710 antibiotic agent Drugs 0.000 abstract 1
125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 abstract 1
125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 abstract 1
125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 abstract 1
210000000987 immune system Anatomy 0.000 abstract 1
125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 abstract 1
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Chemical group O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 abstract 1
WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical group CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
125000004044 trifluoroacetyl group Chemical group FC(C(=O)*)(F)F 0.000 abstract 1
229960005486 vaccine Drugs 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
- C07H5/04—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to nitrogen
- C07H5/06—Aminosugars
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
- C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/12—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by acids having the group -X-C(=X)-X-, or halides thereof, in which each X means nitrogen, oxygen, sulfur, selenium or tellurium, e.g. carbonic acid, carbamic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biochemistry (AREA)
Biotechnology (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Microbiology (AREA)
Epidemiology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Mycology (AREA)
Rheumatology (AREA)
Virology (AREA)
Gastroenterology & Hepatology (AREA)
Pulmonology (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Cosmetics (AREA)
Seasonings (AREA)
Hydrogenated Pyridines (AREA)

DK287886A 1985-06-20 1986-06-19 N-(2-aminoacylamido-2-desoxyhexosyl)-amider, -carbamater og -urinstoffer, deres fremstilling og anvendelse som laegemidler samt mellemprodukter ved fremstillingen DK287886A (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE19853521994 DE3521994A1 (de)	1985-06-20	1985-06-20	N-(2-aminoacylamido-2-desoxy-hexosyl)-amide-, -carbamate und -harnstoffe, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln

Publications (2)

Publication Number	Publication Date
DK287886D0 true DK287886D0 (da)	1986-06-19
DK287886A DK287886A (da)	1986-12-21

Family

ID=6273684

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK287886A DK287886A (da)	1985-06-20	1986-06-19	N-(2-aminoacylamido-2-desoxyhexosyl)-amider, -carbamater og -urinstoffer, deres fremstilling og anvendelse som laegemidler samt mellemprodukter ved fremstillingen

Country Status (21)

Country	Link
US (1)	US4855283A (da)
EP (1)	EP0206037B1 (da)
JP (1)	JPH07116207B2 (da)
KR (1)	KR930011281B1 (da)
CN (1)	CN86104185A (da)
AT (1)	ATE71631T1 (da)
AU (1)	AU564222B2 (da)
CA (1)	CA1289952C (da)
CS (1)	CS270209B2 (da)
DE (2)	DE3521994A1 (da)
DK (1)	DK287886A (da)
ES (2)	ES8801769A1 (da)
FI (1)	FI84833C (da)
GR (1)	GR861574B (da)
HU (1)	HU206123B (da)
IE (1)	IE58918B1 (da)
IL (1)	IL79126A (da)
NO (1)	NO166002C (da)
PH (1)	PH26775A (da)
PT (1)	PT82796B (da)
ZA (1)	ZA864571B (da)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3812681A1 (de) *	1988-04-16	1989-11-02	Bayer Ag	Substituierte n-glycosylamide, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
US5977336A (en) *	1993-03-16	1999-11-02	St. Louis University	High molecular weight surface proteins of non-typeable haemophilus
US5905071A (en) *	1993-08-30	1999-05-18	Bayer Aktiengesellschaft	Glycosylamides of 2-aminoacylamino-2-deoxy sugars
NZ275772A (en) *	1993-11-08	1998-04-27	Connaught Lab	Haemophilus transferrin receptor genes and proteins including production and use
US6361779B1 (en)	1993-11-08	2002-03-26	Aventis Pasteur Limited	Transferrin receptor genes
US6764682B1 (en) *	1994-06-16	2004-07-20	Aventis Pasteur Limited	Adjuvant compositions containing more than one adjuvant
US6440425B1 (en)	1995-05-01	2002-08-27	Aventis Pasteur Limited	High molecular weight major outer membrane protein of moraxella
US6335018B1 (en) *	1995-05-01	2002-01-01	Aventis Pasteur Limited	High molecular weight major outer membrane protein of moraxella
ATE221081T1 (de)	1995-05-04	2002-08-15	Aventis Pasteur	Azelluläre pertussis-impfstoffe und verfahren zu deren herstellung
US5827654A (en) *	1995-05-08	1998-10-27	University Of Toronto	Basal body rod protein genes of campylobacter
US6251405B1 (en)	1995-06-07	2001-06-26	Connaught Laboratories, Inc.	Immunological combination compositions and methods
US5780606A (en) *	1995-06-07	1998-07-14	Connaught Laboratories Limited	Neisseria meningitidis capsular polysaccharide conjugates
US6290971B1 (en) *	1995-06-15	2001-09-18	Aventis Pasteur Limited	Adjuvant compositions comprising a mineral salt and another immunostimulating compound
US6048539A (en) *	1995-11-02	2000-04-11	Connaught Laboratories Limited	Lactoferrin receptor protein
FR2746643B1 (fr) *	1996-04-01	1998-06-12	Techni Pharma	Nouvelles compositions laxatives et leur procede de fabrication
BRPI9710460B8 (pt)	1996-07-02	2021-05-25	Aventis Pasteur	composição imunogênica multi-valente e composição de vacina
US6042820A (en)	1996-12-20	2000-03-28	Connaught Laboratories Limited	Biodegradable copolymer containing α-hydroxy acid and α-amino acid units
FR2762788B1 (fr) *	1997-04-30	2000-10-06	Pasteur Merieux Serums Vacc	Composition vaccinale anti-helicobacter pour usage par voie systemique sous-diaphragmatique
JP2002505665A (ja) *	1997-04-30	2002-02-19	メリュー・オラバックス	Ｔｈ１型アジュバントを含有する抗ヘリコバクターワクチン組成物
FR2762787B1 (fr) *	1997-04-30	2000-10-06	Pasteur Merieux Serums Vacc	Composition vaccinale anti-helicobacter comprenant un adjuvant de type th1
US5977337A (en) *	1997-06-03	1999-11-02	Connaught Laboratories Limited	Lactoferrin receptor genes of Moraxella
US7459524B1 (en)	1997-10-02	2008-12-02	Emergent Product Development Gaithersburg Inc.	Chlamydia protein, sequence and uses thereof
US6335182B1 (en)	1999-03-16	2002-01-01	Aventis Pasteur Limited	Recombinant Haemophilus influenzae adhesin proteins
US7785609B1 (en)	1999-03-16	2010-08-31	Sanofi Pasteur Limited	Recombinant Haemophilus influenzae adhesin proteins
US7241449B1 (en)	1999-04-12	2007-07-10	Aventis Pasteur Limited	Transferrin receptor genes of moraxella
ATE395930T1 (de)	1999-10-22	2008-06-15	Aventis Pasteur	Verfahren zur erregung und/oder verstärkung der immunantwort gegen tumorantigene
GB0000891D0 (en) *	2000-01-14	2000-03-08	Allergy Therapeutics Ltd	Formulation
DK1282702T3 (da)	2000-05-10	2007-04-02	Sanofi Pasteur Ltd	Immunogene polypeptider, som er kodet af KAGE-minigener, og anvendelser deraf
AUPS143402A0 (en) *	2002-03-28	2002-05-09	Alchemia Pty Ltd	Anomeric derivatives of monosaccharides
US8506959B2 (en)	2002-11-01	2013-08-13	Neotope Biosciences Limited	Prevention and treatment of synucleinopathic and amyloidogenic disease
TW200509968A (en)	2002-11-01	2005-03-16	Elan Pharm Inc	Prevention and treatment of synucleinopathic disease
ES2352671T3 (es) *	2002-11-26	2011-02-22	Eurocine Vaccines Ab	Nuevo adyuvante a base de amina.
US7358331B2 (en)	2003-05-19	2008-04-15	Elan Pharmaceuticals, Inc.	Truncated fragments of alpha-synuclein in Lewy body disease
SI1633189T1 (sl)	2003-05-19	2017-12-29	Prothena Biosciences Limited	Skrajšani fragmenti alfa-sinukleina pri bolezni Lewyjevih telesc
MX2007001679A (es)	2004-08-09	2007-05-23	Elan Pharm Inc	Prevencion y tratamiento de la enfermedad sinucleinopatica y amiloidogenica.
UA90569C2 (ru) *	2006-01-26	2010-05-11	Пфайзер Продактс Инк.	Композиция гликолипидного адьюванта (варианты) и способ ее получения
ME00045B (me) *	2006-01-26	2010-10-10	Zoetis Services Llc	Nove kompozicije glikolipidnog adjuvansa
HUE025225T2 (en)	2007-02-23	2016-02-29	Prothena Biosciences Ltd	Prevention and treatment of synucleinopathic and amyloidogenic diseases
PL2118300T3 (pl)	2007-02-23	2015-11-30	Prothena Biosciences Ltd	Zapobieganie i leczenie synukleinopatii i amyloidozy
GB2450088A (en) *	2007-06-11	2008-12-17	Diosamine Dev Corp	Optionally modified monosaccharides with imine/iminium or glycosidic amine/ammonium group for use in modifying the level of cytokines & in therapy
JO3076B1 (ar)	2007-10-17	2017-03-15	Janssen Alzheimer Immunotherap	نظم العلاج المناعي المعتمد على حالة apoe
DK2237803T3 (da)	2007-12-28	2015-10-05	Prothena Biosciences Ltd	Behandling og profylakse af amyloidose
EP2196196A1 (en)	2008-12-10	2010-06-16	Medipol S.A.	Compound, medicament, vaccine composition and nanocapsules
GB201000196D0 (en) *	2010-01-07	2010-02-24	Galvez Julian M	Novel combination
EP3705133B1 (en)	2010-05-14	2024-06-26	Baxalta Incorporated	Ospa chimeras and use thereof in vaccines
JP2015524802A (ja)	2012-07-27	2015-08-27	バクスター・インターナショナル・インコーポレイテッドＢａｘｔｅｒＩｎｔｅｒｎａｔｉｏｎａｌＩｎｃｏｒｐ０Ｒａｔｅｄ	キメラｏｓｐａ分子を含む組成物およびその使用方法
CN104628802B (zh) *	2013-11-07	2017-01-18	北大方正集团有限公司	从发酵液中提取并纯化尼莫克汀的方法
EP3071974A2 (en)	2013-11-19	2016-09-28	Prothena Biosciences Limited	Monitoring immunotherapy of lewy body disease from constipation symptoms
EP3028711A1 (en) *	2014-12-05	2016-06-08	Gubra ApS	Molecular building blocks capable of assembling carbohydrate derivatives, fatty acid residues and peptides
AU2016297529B2 (en) *	2015-07-20	2021-09-09	Zoetis Services Llc	Liposomal adjuvant compositions
US10456459B2 (en) *	2015-07-20	2019-10-29	Zoetis Services Llc	Liposomal adjuvant compositions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3213650A1 (de) *	1982-04-14	1983-10-27	Bayer Ag, 5090 Leverkusen	N-glycosylierte carbonsaeureamid-derivate, verfahren zu ihrer herstellung sowie ihre verwendung zur beeinflussung der koerpereigenen abwehr
DE3344257A1 (de) *	1983-12-07	1985-06-13	Bayer Ag, 5090 Leverkusen	Substituierte o-acyl-glycosylamide, verfahren zu iherer herstellung sowie ihre verwendung

1985
- 1985-06-20 DE DE19853521994 patent/DE3521994A1/de not_active Withdrawn
1986
- 1986-06-03 NO NO862199A patent/NO166002C/no unknown
- 1986-06-05 DE DE8686107665T patent/DE3683410D1/de not_active Expired - Lifetime
- 1986-06-05 EP EP86107665A patent/EP0206037B1/de not_active Expired - Lifetime
- 1986-06-05 AT AT86107665T patent/ATE71631T1/de not_active IP Right Cessation
- 1986-06-16 US US06/874,983 patent/US4855283A/en not_active Expired - Lifetime
- 1986-06-17 IL IL79126A patent/IL79126A/xx not_active IP Right Cessation
- 1986-06-18 FI FI862619A patent/FI84833C/fi not_active IP Right Cessation
- 1986-06-18 AU AU58979/86A patent/AU564222B2/en not_active Expired
- 1986-06-18 CS CS864513A patent/CS270209B2/cs unknown
- 1986-06-18 JP JP61140434A patent/JPH07116207B2/ja not_active Expired - Lifetime
- 1986-06-18 PH PH33904A patent/PH26775A/en unknown
- 1986-06-18 CA CA000511894A patent/CA1289952C/en not_active Expired - Lifetime
- 1986-06-18 GR GR861574A patent/GR861574B/el unknown
- 1986-06-19 HU HU862584A patent/HU206123B/hu unknown
- 1986-06-19 PT PT82796A patent/PT82796B/pt not_active IP Right Cessation
- 1986-06-19 DK DK287886A patent/DK287886A/da not_active Application Discontinuation
- 1986-06-19 KR KR8604878A patent/KR930011281B1/ko not_active Expired - Lifetime
- 1986-06-19 ES ES556287A patent/ES8801769A1/es not_active Expired
- 1986-06-19 ZA ZA864571A patent/ZA864571B/xx unknown
- 1986-06-19 IE IE163686A patent/IE58918B1/en not_active IP Right Cessation
- 1986-06-20 CN CN198686104185A patent/CN86104185A/zh active Pending
1987
- 1987-09-15 ES ES557729A patent/ES8900231A1/es not_active Expired

Also Published As

Publication number	Publication date
AU564222B2 (en)	1987-08-06
IE58918B1 (en)	1993-12-01
PT82796A (en)	1986-07-01
ES557729A0 (es)	1989-04-16
KR870000354A (ko)	1987-02-18
FI862619A7 (fi)	1986-12-21
DK287886A (da)	1986-12-21
DE3683410D1 (de)	1992-02-27
ES8801769A1 (es)	1988-02-16
ZA864571B (en)	1987-02-25
FI862619A0 (fi)	1986-06-18
HU206123B (en)	1992-08-28
ES556287A0 (es)	1988-02-16
US4855283A (en)	1989-08-08
NO862199L (no)	1986-12-22
NO862199D0 (no)	1986-06-03
EP0206037A2 (de)	1986-12-30
NO166002B (no)	1991-02-04
PH26775A (en)	1992-10-13
ES8900231A1 (es)	1989-04-16
KR930011281B1 (en)	1993-11-29
FI84833B (fi)	1991-10-15
JPS61293991A (ja)	1986-12-24
EP0206037A3 (en)	1988-02-03
ATE71631T1 (de)	1992-02-15
EP0206037B1 (de)	1992-01-15
FI84833C (fi)	1992-01-27
AU5897986A (en)	1986-12-24
CS451386A2 (en)	1989-10-13
DE3521994A1 (de)	1987-01-02
CS270209B2 (en)	1990-06-13
IL79126A0 (en)	1986-09-30
CN86104185A (zh)	1987-04-08
GR861574B (en)	1986-10-17
HUT41049A (en)	1987-03-30
CA1289952C (en)	1991-10-01
IE861636L (en)	1986-12-20
JPH07116207B2 (ja)	1995-12-13
PT82796B (pt)	1988-12-15
NO166002C (no)	1991-05-15
IL79126A (en)	1991-09-16

Legal Events

Date	Code	Title	Description
2004-10-18	ARF	Application refused

Publication	Publication Date	Title
DK287886A (da)	1986-12-21	N-(2-aminoacylamido-2-desoxyhexosyl)-amider, -carbamater og -urinstoffer, deres fremstilling og anvendelse som laegemidler samt mellemprodukter ved fremstillingen
NO812311L (no)	1982-01-11	Bronchospasmolytisk virksomme forbindelser og fremgangsmaate for deres fremstilling
GR78496B (da)	1984-09-27
MY106314A (en)	1995-04-29	New tetrazole derivatives, process for their preparation and their use
DK499088A (da)	1989-04-03	1-oe(2-pyrimidinyl)-aminoalkylaapiperidinderivater, fremgangsmaade til fremstilling deraf og laegemiddel indeholdende saadanne derivater
DK0399519T3 (da)	1996-09-02	Potensering af celleformidlet immunitet under anvendelse af polyaminderivater
DK191587D0 (da)	1987-04-14	1,5-benzothiazepinderivater, fremgangsmaade og mellemprodukt til brug ved deres fremstilling samt laegemiddel indeholdende disse
DE3366181D1 (en)	1986-10-23	2-aminomethyl-6-sulfamoylphenol derivatives, process for their preparation, their use and pharmaceutical preparations based on these compounds
NO861923L (no)	1986-11-18	Nye isoksazolderivater, fremgangsmaate til deres fremstilling, og farmasoeytiske preparater inneholdende dem.
DK96086A (da)	1986-09-05	8-thiotetrahydroquinolinderivater, deres fremstilling og anvendelse som laegemidler